Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender

Our study aimed to analyze the correlation of cancer-related parameters with tumor regression grade (TRG) and disease-free survival (DFS) by gender in 192 rectal cancer patients operated on after neoadjuvant long-course chemoradiotherapy (LCCRT). Preoperative diagnostics revealed no significant g...

Full description

Saved in:
Bibliographic Details
Main Authors: Velda Smajlbegović, Snježana Ramić, Iva Kirac, Meliha Solak Mekić, Loris Ćurt, Danko Velimir Vrdoljak
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2024-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:https://hrcak.srce.hr/file/481883
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849320398667120640
author Velda Smajlbegović
Snježana Ramić
Iva Kirac
Meliha Solak Mekić
Loris Ćurt
Danko Velimir Vrdoljak
author_facet Velda Smajlbegović
Snježana Ramić
Iva Kirac
Meliha Solak Mekić
Loris Ćurt
Danko Velimir Vrdoljak
author_sort Velda Smajlbegović
collection DOAJ
description Our study aimed to analyze the correlation of cancer-related parameters with tumor regression grade (TRG) and disease-free survival (DFS) by gender in 192 rectal cancer patients operated on after neoadjuvant long-course chemoradiotherapy (LCCRT). Preoperative diagnostics revealed no significant gender differences in any clinical parameters other than obesity (p=0.031). We found that slightly overweight men had a lower incidence of distant metastases (p=0.042). The post-LCCRT pathologic finding showed that women had more positive lymph nodes (ypN, p=0.002) while no other pathologic parameter differed significantly between the genders. Overall, a poor response to therapy correlated with a shorter time to disease progression (p=0.002). Women achieved ypN0 in 50% of cases, but only 27% had a good TRG compared to 40.5% of men (p=0.073). Women had a worse DFS than men, even when complete response to therapy was achieved (p=0.003), and greater depth of residual tumor invasion (ypT, p=0.035) and higher ypN (p=0.002) correlated with shorter DFS. Positive resection margins (p<0.001), higher ypN stage (p=0.003), and poor TRG (p=0.025) correlated with shorter DFS in men. We conclude that women have a poorer response to LCCRT with the possibility that therapeutic approach to the neoadjuvant treatment of rectal cancer may be gender-specific.
format Article
id doaj-art-695bb93102744a3493eec558a153cd43
institution Kabale University
issn 0353-9466
1333-9451
language English
publishDate 2024-01-01
publisher Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
record_format Article
series Acta Clinica Croatica
spelling doaj-art-695bb93102744a3493eec558a153cd432025-08-20T03:50:06ZengSestre Milosrdnice University hospital, Institute of Clinical Medical ResearchActa Clinica Croatica0353-94661333-94512024-01-0163.3-452353210.20471/acc.2024.63.04.10Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient GenderVelda Smajlbegović0Snježana Ramić1Iva Kirac2Meliha Solak Mekić3Loris Ćurt4Danko Velimir Vrdoljak5Department of Oncology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and HerzegovinaOncologic Pathology, Ljudevit Jurak Department of Pathology and Cytology, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaSurgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDivision of Oncology and Radiotherapy, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaSurgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaSurgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaOur study aimed to analyze the correlation of cancer-related parameters with tumor regression grade (TRG) and disease-free survival (DFS) by gender in 192 rectal cancer patients operated on after neoadjuvant long-course chemoradiotherapy (LCCRT). Preoperative diagnostics revealed no significant gender differences in any clinical parameters other than obesity (p=0.031). We found that slightly overweight men had a lower incidence of distant metastases (p=0.042). The post-LCCRT pathologic finding showed that women had more positive lymph nodes (ypN, p=0.002) while no other pathologic parameter differed significantly between the genders. Overall, a poor response to therapy correlated with a shorter time to disease progression (p=0.002). Women achieved ypN0 in 50% of cases, but only 27% had a good TRG compared to 40.5% of men (p=0.073). Women had a worse DFS than men, even when complete response to therapy was achieved (p=0.003), and greater depth of residual tumor invasion (ypT, p=0.035) and higher ypN (p=0.002) correlated with shorter DFS. Positive resection margins (p<0.001), higher ypN stage (p=0.003), and poor TRG (p=0.025) correlated with shorter DFS in men. We conclude that women have a poorer response to LCCRT with the possibility that therapeutic approach to the neoadjuvant treatment of rectal cancer may be gender-specific.https://hrcak.srce.hr/file/481883Rectal cancerNeoadjuvant chemoradiotherapyGenderTumor regression gradeDisease-free survival
spellingShingle Velda Smajlbegović
Snježana Ramić
Iva Kirac
Meliha Solak Mekić
Loris Ćurt
Danko Velimir Vrdoljak
Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
Acta Clinica Croatica
Rectal cancer
Neoadjuvant chemoradiotherapy
Gender
Tumor regression grade
Disease-free survival
title Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
title_full Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
title_fullStr Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
title_full_unstemmed Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
title_short Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
title_sort tumor response to neoadjuvant long course chemoradiotherapy depends on the rectal cancer patient gender
topic Rectal cancer
Neoadjuvant chemoradiotherapy
Gender
Tumor regression grade
Disease-free survival
url https://hrcak.srce.hr/file/481883
work_keys_str_mv AT veldasmajlbegovic tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender
AT snjezanaramic tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender
AT ivakirac tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender
AT melihasolakmekic tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender
AT loriscurt tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender
AT dankovelimirvrdoljak tumorresponsetoneoadjuvantlongcoursechemoradiotherapydependsontherectalcancerpatientgender